Stonebridge Capital Advisors’s Cardiovascular Systems, Inc. CSII Stock Holding History

Stonebridge Capital Advisors’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-600	Closed	-$11.9K	–	1020
2023 Q1	$11.9K	Hold	600	–	–	﹤0.01%	587
2022 Q4	$8.17K	Hold	600	–	–	﹤0.01%	634
2022 Q3	$8K	Hold	600	–	–	﹤0.01%	627
2022 Q2	$9K	Hold	600	–	–	﹤0.01%	630
2022 Q1	$14K	Hold	600	–	–	﹤0.01%	615
2021 Q4	$11K	Hold	600	–	–	﹤0.01%	629
2021 Q3	$20K	Hold	600	–	–	﹤0.01%	501
2021 Q2	$26K	Hold	600	–	–	﹤0.01%	456
2021 Q1	$23K	Buy	+600	New	+$25.5K	﹤0.01%	486
2020 Q3	–	Sell	-600	Closed	-$19K	–	761
2020 Q2	$19K	Hold	600	–	–	﹤0.01%	412
2020 Q1	$21K	Hold	600	–	–	﹤0.01%	376
2019 Q4	$29K	Hold	600	–	–	﹤0.01%	399
2019 Q3	$29K	Hold	600	–	–	0.01%	396
2019 Q2	$26K	Buy	+600	New	+$23.3K	﹤0.01%	419

Other funds holding CSII

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Stonebridge Capital Advisors's CSII Position: Q2 2023 in Review

Stonebridge Capital Advisors sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 600 shares — an estimated $11.9K sold.

Stonebridge Capital Advisors first reported a position in CSII in Q2 2019 and held it in 14 quarters. The position peaked at $29K in Q4 2019. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

Stonebridge Capital Advisors reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
Stonebridge Capital Advisors sold 600 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $11.9K.
Stonebridge Capital Advisors first reported a position in Cardiovascular Systems, Inc. in Q2 2019 and held it in 14 quarters.
Stonebridge Capital Advisors's Cardiovascular Systems, Inc. position peaked at $29K in Q4 2019.
2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q2 2023, filed 23 Aug 2023.